Background. Surgical antimicrobial prophylaxis (SAP) is standard of care in clean surgery involving implants and in clean-contaminated surgical procedures. Timing of application of the antibiotic remains a debate: WHO recently extended the time prior to incision from 60 to 120 minutes, while CDC considers the availabdata insufficient to provide evidence-based guideline for timing. In addition, studies to date included different types of antibiotics with different T ½. Therefore, we prospectively followed 250'000 patients to further define the optimal timing for SAP Methods. The Swiss national center for infection prevention (www.swissnoso. ch) started surveillance for surgical site infection (SSI) in 2009. Currently, 172 institutions participate throughout Switzerland, with routine postdicharge surveillance (adherence >90%) and on-site quality audits by a physician or infection control practitioner. The data collection includes age, sex, type of surgery, timing of SAP in minutes prior to incision, BMI, ASA score, antimicrobial agent. Inclusion criteria for this study were: adult patients undergoing cardiac surgery, orthopedic or abdominal surgery, antimicrobial prophylaxis with cefuroxime only (+metronidazole for abdominal surgery) and pathogen identified in cases of SSI was cefuroxime-susceptible. Data were analyzed using a generalized additive model (GAM) to allow non-parametric fits with relaxed assumptions on the actual relationship between response and predictor Results. Of the 258'481 patients in the national SSI surveillance database 121'645 fulfilled the inclusion criteria (38% of patients did not require SAP, 18% had surgery with contaminated or dirty wounds, 2.7% were <18 years and data on timing and class of antibiotic were missing in 5.7%). The lowest risk of SSI was observed with application of SAP 0-30min prior incision, even after adjustment for age, sex, ASA score, type of surgery, BMI, and T1/2. ( A reported penicillin allergy may compromise receipt of recommended antibiotic prophylaxis intended to prevent surgical site infections (SSI). Most patients with a reported penicillin allergy are not allergic, and would tolerate recommended cephalosporin prophylaxis. Our objective was to determine the impact of a reported penicillin allergy on the development of SSIs.
Methods. In this retrospective cohort study of patients who underwent hip arthroplasty, knee arthroplasty, hysterectomy, colon surgery, or coronary artery bypass grafting (CABG) from 2010 through 2014 at Massachusetts General Hospital, we compared patients with and without a reported penicillin allergy. The primary outcome was a SSI, as defined by the Centers for Disease Control and Prevention's National Healthcare Safety Network. The secondary outcome was perioperative antibiotic use.
Results. Of 8,385 patients who underwent 9,004 procedures, 922 (11%) reported a penicillin allergy and 241 (2.7%) had a SSI. In multivariable logistic regression analysis, patients reporting a penicillin allergy had a 1.51 [1.02, 2.22] increased odds of developing a SSI. Penicillin allergy reporters were administered less cefazolin (12% vs 92%, P < 0.001) and more clindamycin (49% vs 3%, P < 0.001), vancomycin (35% vs 3%, P < 0.001), and gentamicin (24% vs 3%, P < 0.001) compared with those without a reported penicillin allergy (Figure) . The increased SSI risk among patients reporting penicillin allergy was mediated by the patients' receipt of a alternative perioperative antibiotic; from 112 to 124 patients with reported penicillin allergy would need allergy evaluation to prevent one SSI.
Conclusion. Patients with a reported penicillin allergy had a 50% increased odds of SSI, attributable to the receipt of second-line perioperative antibiotics. Clarification of penicillin allergies as part of routine preoperative care may decrease SSI risk. Background. Surgical site infections (SSIs) continue to occur due to improper perioperative antibiotic choice, timing, inadequate dosing or redosing. Internal data revealed that appropriate intraoperative antibiotic redosing rates in 2014 were low. Our multidisciplinary team implemented a quality improvement intervention in January 2016 to increase compliance with surgical prophylaxis guideline recommendations, with a focus on appropriate intraoperative antibiotic redosing.
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Impact of a Guideline-Driven Quality Improvement Intervention on
Methods. A retrospective, observational study was conducted for all surgeries performed at the University of Iowa Hospitals and Clinics between September 1, 2014 and April 30, 2017 . Two months of data before and after the intervention were censored for analysis. The primary outcome was failure to meet intraoperative antibiotic redosing criteria for procedures lasting greater than 4 hours in the pre-and post-intervention period, analyzed by Chi-square test. Monthly total procedures and the number lasting greater than 4 hours were analyzed between periods by independent-samples t-test. Hospital SSI rates were trended throughout the study period.
Results. There were 14 months of data both pre-and post-intervention and 48,781 total surgical procedures were analyzed. The mean total number of surgical procedures monthly were 1,733 pre-and 1,750 post-intervention (P = 0.55). The monthly mean number of procedures lasting greater than 4 hours were 235 pre-and 249 post-intervention (P = 0.06). For surgeries lasting greater than 4 hours, 1,968 (59.7%) failed to meet redosing criteria pre-and 1,407 (40.2%) post-intervention (P < 0.01). Hospital SSI rates for fiscal year 2015, 2016, and 2017 (data through December) were 2.4, 2.1, and 1.8 infections per 100 procedures, respectively.
Conclusion. The quality improvement intervention significantly reduced the number of intraoperative antibiotic redosing failures in procedures lasting greater than 4 hours. The number of procedures performed in the pre-and post-intervention periods were not significantly different. Trends in SSIs declined during the study period. Further study is warranted to determine the direct impact of improved antibiotic redosing compliance on SSI rates.
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